Authors: Legendre, CM Norman, DJ Keating, MR Maclaine, GDH Grant, DM

Citation: Cm. Legendre et al., Valaciclovir prophylaxis of cytomegalovirus infection and disease in renaltransplantation: an economic evaluation., TRANSPLANT, 70(10), 2000, pp. 1463-1468

Authors: Kim, WR Badley, AD Wiesner, RH Porayko, MK Seaberg, EC Keating, MR Evans, RW Dickson, ER Krom, RAF Paya, CV

Citation: Wr. Kim et al., The economic impact of cytomegalovirus infection after liver transplantation, TRANSPLANT, 69(3), 2000, pp. 357-361

Authors: Keating, MR Steckelberg, JM

Citation: Mr. Keating et Jm. Steckelberg, Editorial response: Orthopedic prosthesis salvage, CLIN INF D, 29(2), 1999, pp. 296-297

Authors: Lowance, D Keating, MR

Citation: D. Lowance et Mr. Keating, Valacyclovir to prevent cytomegalovirus disease after renal transplantation - Reply, N ENG J MED, 341(12), 1999, pp. 921-921

Authors: Lowance, D Neumayer, HH Legendre, CM Squifflet, JP Kovarik, J Brennan, PJ Norman, D Mendez, R Keating, MR Coggon, GL Crisp, A Lee, IC

Citation: D. Lowance et al., Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation, N ENG J MED, 340(19), 1999, pp. 1462-1470

Authors: Keating, MR

Citation: Mr. Keating, Antiviral agents for non-human immunodeficiency virus infections, MAYO CLIN P, 74(12), 1999, pp. 1266-1283